> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint FDA Panel to Meet About Achondroplasia Treatments
- URL: https://www.fdaweb.com/joint-fda-panel-to-meet-about-achondroplasia-treatments/
- Published: 2018-04-25T12:00:00.000Z
- Updated: 2026-09-15T00:00:59.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141297

*Federal Register* notice: FDA has announced a 5/11 joint Pediatric Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee meeting. Panel members are scheduled to discuss drug development for treating children with achondroplasia. Topics to be discussed include the evidence required to establish dose-response, study design, study duration, intended population, and endpoints. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-08766.pdf?ref=fdaweb.com).